Cannabis in Sweden
Cannabis in Sweden has no officially recognized medical usage and medical use is not seen as an extenuating circumstance. Rather the opposite, in a case that drew some attention in the national press involving a multiple sclerosis patient, the disease, and the fact that she stated that cannabis helped her, were seen as an aggravated circumstance by the court. The court argued in the verdict that she lacked motivation to stop using the drug and therefore gave her an unconditioned jail sentence, although she was a first-time offender, she would have otherwise regularly been given a suspended sentence or a fine.[1][2]
The Medical Products Agency reported in 2008 that no drugs containing cannabinoids are available, although they can have beneficial effects on symptoms like neuralgia.[3] Cannabinoid mouth spray Sativex that is derived from cannabis plants was approved in Sweden for the treatment of spasticity due to Multiple Sclerosis on 22 December 2011.[4]
Research on cannabinoids is done at the famous Karolinska Institutet.[5]
References
- ↑ Hadley-Kamptz, Isobel (23 January 2008). "080123: Ett övergrepp". Expressen (in Swedish). Retrieved 2009-04-05.
I domen nämns Susannes MS som en försvårande omständighet. Eftersom hon betraktar marijuana som effektiv medicin mot sin sjukdom anses hon inte vara motiverad till en drogfri tillvaro." / "In the verdict Susanne's MS is seen as a aggravating circumstance. Since she regards marijuana as an effective drug against her decease, she is not considered to be motivated to live drug-free life.
- ↑ O'Mahony, Paul (25 January 2008). "MS patient jailed for cannabis use". The Local. Retrieved 2009-04-05.
- ↑ "Läkemedelsbehandling av nervsmärta" (in Swedish). Medical Products Agency. 2008-01-17.
- ↑ "Sativex® approved in Sweden for the treatment of spasticity due to Multiple Sclerosis (MS)". GW Pharmaceuticals. 22 December 2011. Archived from the original on 11 March 2016. Retrieved 21 November 2016.
- ↑ "Reports about THC, Karolinska Institutet". siteseeker.se.
